Alfredo Fusco, a cancer researcher in Italy who is facing a criminal investigation for fraud, has had two more papers retracted.
Category: oncology retractions
University of Maryland researchers notch second retraction
Two researchers at the University of Maryland who retracted a paper earlier this year for a duplicated figure have withdrawn another, this time for unknown reasons.
The Journal of Biological Chemistry (JBC) paper has been cited 16 times, according to Thomson Scientific’s Web of Knowledge.
Here’s the notice, for “Hsp90 Interaction with INrf2(Keap1) Mediates Stress-induced Nrf2 Activation,” which is unfortunately a return to the JBC’s opacity: Continue reading University of Maryland researchers notch second retraction
Wrong cell line leads to retraction of kidney cancer study
A group of authors in China has retracted their December 2013 paper in PLoS ONE after realizing that they’d been studying the wrong cells.
The paper, “Up-Regulation of pVHL along with Down-Regulation of HIF-1α by NDRG2 Expression Attenuates Proliferation and Invasion in Renal Cancer Cells,” came from Lei Gao, of the Fourth Military Medical University, in Xi’an, and colleagues. It purported to find that:
Continue reading Wrong cell line leads to retraction of kidney cancer study
Brutal honesty: Author takes to PubPeer to announce retraction — and tells us she’ll lose PhD, professorship
Over the past week, there have been a number of comments on PubPeer — a site of which we’re big fans — about a 2007 paper in Oncogene.
The comments suggested that the figures in the paper had problems. Some bands seemed to be duplicated, and one of the images looked very much like that of another paper.
Then, today, first author Eriko Suzuki left this comment: Continue reading Brutal honesty: Author takes to PubPeer to announce retraction — and tells us she’ll lose PhD, professorship
Bogus Western blots lead to retraction of cancer paper
A group of Italian researchers has retracted their 2013 paper on colorectal cancer because one of the authors, they, say, was tinkering with the data.
The article, “PBOX-15 induces apoptosis and improves the efficacy of oxaliplatin in human colorectal cancer cell lines,” appeared in the European Journal of Pharmacology in August. The first author was Giuseppina Gangemi, of the University of Salerno.
The paper purported to find that:
Continue reading Bogus Western blots lead to retraction of cancer paper
Why was that lung cancer paper retracted? The “authors’ reason,” of course
Two researchers who wrote a review article on the genetics of lung cancer have retracted the paper. But why evidently is for them to know and us to find out.
The article, “Epigenetic aberrant methylation of tumor suppressor genes in small cell lung cancer,” was published in the August 2013 issue of the Journal of Thoracic Disease by authors from Shandong University in China.
According to the retraction notice: Continue reading Why was that lung cancer paper retracted? The “authors’ reason,” of course
“Knowledgeable informant” topples ovarian cancer paper
A group of cancer researchers in China has lost their 2013 paper in the International Journal of Clinical and Experimental Pathology after someone tipped off the journal that the data were copied.
The article, “Importance of spondin 1 and cellular retinoic acid binding protein 1 in the clinical diagnosis of ovarian cancer,” came from Ting-Ting Jiao, Ye-Min Zhang, Lin Yao, Yuan Gao, Jian Sun, Dong-Fang Zou, Guo-Ping Wu, Dan Wang, Jun Ou, Ning Hui, who work at various Shanghai hospitals.
Here’s the retraction notice: Continue reading “Knowledgeable informant” topples ovarian cancer paper
IRB mishap costs MD Anderson team a paper on prostate cancer
A group of researchers from MD Anderson Cancer Center in Houston has lost a 2013 paper in BJU International for running afoul of their institution’s ethics review board, and of military reviewers, as well.
The paper, “Many young men with prostate-specific antigen (PSA) screen-detected prostate cancers may be candidates for active surveillance,” looked at prostate cancer screening in men 55 and under — considered young for the older-man’s disease. According to the abstract: Continue reading IRB mishap costs MD Anderson team a paper on prostate cancer
Dispute with “unlisted author whose claim to authorship could not be solved” topples cancer paper
Cancer Science, the journal of the Japanese Cancer Association, has retracted a 2012 article by a group of researchers because, well, it wasn’t clear who made up the group in the first place.
The article, “Antitumor activity of human γδ T cells transducted with CD8 and with T-cell receptors of tumor-specific cytotoxic T lymphocytes,” appeared online in July 2012 and was written, ostensibly, by Takeshi Hanagiri, Yoshiki Shigematsu, Koji Kuroda, Tetsuro Baba, Hironobu Shiota, Yoshinobu Ichiki, Yoshika Nagata, Manabu Yasuda, Tomoko So, Mitsuhiro Takenoyama and Fumihiro Tanaka from the Second Department of Surgery at the University of Occupational and Environmental Health, in Kitakyushu.
The abstract states: Continue reading Dispute with “unlisted author whose claim to authorship could not be solved” topples cancer paper
Former Hopkins and Pitt cancer researcher notches sixth retraction
Robert Getzenberg, a former researcher at Hopkins and Pitt, has retracted a sixth paper, this one in Cancer Research.
Here’s the notice for “Mechanistic Analysis of the Role of BLCA-4 in Bladder Cancer Pathobiology:” Continue reading Former Hopkins and Pitt cancer researcher notches sixth retraction